Social Media Messages for Reducing Teen Vaping

(SMART Trial)

AT
EH
Overseen ByElaine Hanby, MA
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Abramson Cancer Center at Penn Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if social media messages specifically designed for sexual and gender minority (SGM) teens are more effective at preventing vaping than generic messages. Participants will receive either SGM-tailored anti-vaping messages or non-tailored messages via text. This opportunity allows SGM teens who haven’t vaped in the past 30 days and are open to receiving text messages to contribute to research that might help prevent vaping. As an unphased trial, this study offers a unique chance for participants to contribute to pioneering research that could shape future prevention strategies.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this social media intervention is safe for SGM youth?

Research has shown that personalized text message programs can be safe and effective. In one study, teens who received these messages were 35% more likely to quit vaping. The messages, designed to connect with young people, worked well without causing harm.

Additionally, studies have examined using social media to share messages against vaping. This approach raises awareness about vaping's dangers, with no reports of negative effects.

Overall, these methods have been well-received and have not raised safety concerns. They aim to encourage healthy choices and reduce vaping among young people.12345

Why are researchers excited about this trial?

Researchers are excited about using tailored social media messages to reduce teen vaping because this approach is highly personalized and directly engages teens where they spend a lot of their time—on their phones. Unlike traditional anti-vaping campaigns that use generic messages, these tailored messages are customized based on individual characteristics, potentially making them more relatable and effective. This innovative strategy aims to reach teens in a way that feels more personal and relevant, which could lead to a significant impact on reducing vaping among this age group.

What evidence suggests that this trial's social media messages could be effective in reducing teen vaping?

Studies have shown that personalized social media messages can help teens quit vaping. In this trial, participants in the tailored arm will receive customized, interactive text messages about quitting, which research indicates makes them 35% more likely to stop vaping. These messages have increased self-reported quitting rates among young people. The approach uses content that connects with each teen's experiences and challenges with vaping. This strategy has successfully encouraged teens to try quitting and reduced their use of e-cigarettes.12346

Are You a Good Fit for This Trial?

This trial is for sexual and gender minority (SGM) teens aged 13-20 who are interested in the effects of anti-vaping messages. The study aims to prevent vaping initiation by using social media as a platform for health communication, specifically tailored to SGM youth.

Inclusion Criteria

Not vaped or used other tobacco products in the past 3 months
Have access to a smartphone
Identify as SGM
See 4 more

Exclusion Criteria

Current vapers
Non-SGM youth

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Development and Testing

Development of SGM-tailored anti-vaping social media messages and testing through an online discrete choice experiment

4-8 weeks
Online participation

Intervention

Participants receive SGM-tailored or non-tailored anti-vaping messages via text message

4 weeks
Text message delivery

Follow-up

Participants are monitored for susceptibility to vaping and vaping initiation

4 weeks
Online surveys at one week, two weeks, three weeks, and one month

What Are the Treatments Tested in This Trial?

Interventions

  • Tailored
Trial Overview The effectiveness of culturally-tailored anti-vaping social media messages is being tested against non-tailored ones. The goal is to see if these specialized messages can more effectively prevent vaping among SGM teens.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: TailoredExperimental Treatment1 Intervention
Group II: Non-TailoredActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials
425
Recruited
464,000+

University of Florida

Collaborator

Trials
1,428
Recruited
987,000+

Published Research Related to This Trial

Over half (52.5%) of adolescents in Texas reported exposure to tobacco-related social media, highlighting a significant presence of tobacco marketing among youth.
Adolescents who are susceptible to or currently use e-cigarettes and combustible tobacco are more likely to engage with tobacco-related social media, indicating that these platforms could be effective targets for prevention campaigns aimed at vulnerable youth.
Exposure and Engagement With Tobacco- and E-Cigarette-Related Social Media.Hébert, ET., Case, KR., Kelder, SH., et al.[2022]
A significant 59% of middle and high school students reported exposure to pro-tobacco online marketing, which is linked to a higher likelihood of dual use of both electronic and combustible cigarettes, with dual users having 1.73 times the odds of exposure.
The study highlights a potential regulatory gap in the oversight of electronic cigarette marketing, suggesting that further policy actions are needed to protect minors from the influence of pro-tobacco advertising.
Online Pro-Tobacco Marketing Exposure Is Associated With Dual Tobacco Product Use Among Underage US Students.Marion, H., Garner, W., Estrada, A., et al.[2023]
The FDA's anti-vaping campaign, 'The Real Cost,' launched in September 2018, has not significantly reduced the popularity of vaping on Instagram, as evidenced by a three-fold increase in the median 'like' count on vaping-related posts after the campaign.
Despite the campaign's efforts, vaping-related hashtags continued to dominate Instagram, with a notable rise in posts featuring high-nicotine 'pod' devices, indicating that social media marketing still strongly influences adolescent vaping behavior.
#Vape: Measuring E-Cigarette Influence on Instagram With Deep Learning and Text Analysis.Vassey, J., Metayer, C., Kennedy, CJ., et al.[2022]

Citations

A Vaping Cessation Text Message Program for Adolescent ...A tailored, interactive text message program increased self-reported vaping cessation rates among adolescents recruited via social media channels.
A Vaping Cessation Text Message Program for Adolescent ...A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels.
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39110436/
A Vaping Cessation Text Message Program for Adolescent ...A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels.
Text Message Quit Vaping Intervention for Adolescents ...Other quitting-related outcomes include change in motivation to quit, quit attempts, reduction in e-cigarette use, 7-day ppa, and continuous.
JAMA Publishes New Study on Proven Effectiveness of ...First-of-its-kind randomized clinical trial shows teens 35% more likely to quit vaping nicotine with an interactive, tailored text message program.
Sharing Antivaping Social Media MessagesUsing social media messages to encourage sharing about vaping harms among young adults could help establish beliefs that could discourage vaping ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security